An observational study in ICU Nutrition in Resource Limited Settings, sponsored by RESQ Nutri ICU group. Not yet recruiting at 1 site in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by RESQ Nutri ICU group · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this observational study is to develop practical, expert-agreed standards for nutrition care of critically ill adults in intensive care units (ICUs) in resource-limited settings. The main question it aims to answer is:
Which nutrition practices do international ICU experts agree are essential and achievable for critically ill patients in hospitals with limited resources?
Participants will be ICU doctors, dietitians and nurses with experience of nutrition care in resource-limited settings. They will rate a set of statements across five areas of ICU nutrition in anonymous online survey rounds. After each round they will see a summary of the group's responses and may revise their ratings. A statement reaches agreement when at least 80% of experts agree with it, and rounds will continue until responses stabilise. ICU survivors and family members will also review a plain-language version of the statements, and their feedback will be shared with the expert panel.
Background: International ICU nutrition guidelines come almost entirely from trials in high-income settings. Lower-middle-income countries contributed less than 1% of patients and low-income countries none. ICUs that lack dietitians, feeding pumps, indirect calorimetry, post-pyloric access, specialised formulas or laboratory monitoring have no agreed minimum standard. This includes ICUs in low- and middle-income countries, remote or public facilities anywhere, and ICUs during surges. "Resource-limited" here is defined by what resources are available, not by World Bank income group.
Design: This is an international, web-based modified Delphi study reported according to ACCORD. A multidisciplinary Steering Committee drafts and refines the statements and analyses responses but does not vote. An independent Delphi methodologist oversees the process to limit bias. Panellists are recruited by purposive sampling through professional networks and societies, aiming for diversity in profession, geography, sex and resource setting.
Statement development: Round 1 statements come from a systematic search of PubMed, Embase, Scopus, Web of Science, Google Scholar and ESPEN, ASPEN and ESICM guidelines, covering adult literature in English from 2015 to 2026. Two reviewers screen in Rayyan and report selection in a PRISMA diagram. Statements are grouped into five domains: screening and assessment; timing, route and delivery; monitoring and metabolic control; micronutrients and special situations; and team, documentation and quality improvement. An evidence summary goes out with Round 1.
Delphi process: Panellists will rate statements on a 9-point scale, give free-text comments and describe the resource limitations in their practice. In later rounds they receive their own previous rating, the group median and IQR, percentage agreement and anonymised comments. A statement is revised when at least 10% of respondents (at least four) raise the same issue, and revisions that change its meaning are re-rated. Rounds continue until responses are stable, and the panel then approves the final set.
Patient involvement: Five to ten ICU survivors or patient representatives take part in single interviews in their preferred language and rate the value of the Round 1 statements. Their views are fed back to the panel but do not count towards consensus.
Analysis: Consensus to include is at least 80% of ratings at 7-9, and consensus to exclude is at least 80% at 1-3. Stability is tested with the Wilcoxon signed-rank test between consecutive rounds. If attrition exceeds 20%, a sensitivity analysis is run. Exploratory comparisons are made by profession and by income setting.
Ethics: Approved by the Institutional Ethics Committee, Father Muller Medical College (FMIEC/CCM/495/2026), with electronic consent from panellists.
1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.
This study's planned enrollment of 50 is below the median of 140 across 816 observational studies indexed under Critical Illness.
Browse Critical Illness studies →This is the only study on the registry with RESQ Nutri ICU group as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The study population is an international, multidisciplinary panel of about 40 to 50 professionals with expertise in adult critical care nutrition practice, research, education or guideline development. It includes intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers and allied professionals involved in ICU nutrition. At least 60% of the panel will be from low- and middle-income countries or will have current experience of working in resource-limited ICUs, and at least one-third will be non-physicians. In addition, 5 to 10 adult ICU survivors or patient-care representatives, mainly from resource-limited settings, will take part in patient and public involvement interviews.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Panellists will be eligible if they meet all of the following criteria:
Relevant expertise: At least one of the following:
Exclusion Criteria:
International multidisciplinary panel of approximately 40 to 50 experts in adult critical care nutrition, including intensivists, ICU dietitians, critical care nurses, clinical pharmacists and nutrition researchers.At least 60% will be from low- and middle-income countries or resource-limited ICUs, and at least one-third will be non-physicians. Panellists will rate draft statements on minimum nutrition standards over iterative anonymous online rounds until consensus and stability are reached.
To establish consensus-based minimum standards for assessment, initiation, delivery, and monitoring of nutritional therapy in resource-limited ICUs.
Number and proportion of Delphi statements reaching consensus to include (at least 80% of panellists rating 7 to 9 on a 9-point Likert scale) or consensus to exclude (at least 80% rating 1 to 3), with response stability between consecutive rounds (no significant variation on the Wilcoxon signed-rank or Kruskal-Wallis test, p of 0.05 or more). For each statement, the median, interquartile range and percentage agreement will be reported.
Time frame: Through study completion, an average of 18 months
To identify pragmatic adaptations of existing international ICU nutrition guidelines for resource-limited settings.
Number and proportion of statements describing adaptations of ESPEN, ASPEN or ESICM recommendations that reach consensus to include (at least 80% rating 7 to 9) with response stability.
Time frame: Through study completion, an average of 18 months
To identify essential (minimum) nutritional practices for critically ill patients in ICUs
Number and proportion of statements rated "essential" (7 to 9) by at least 80% of panellists with response stability, reported for each of the five domains.
Time frame: Through study completion, an average of 18 months
To identify research priorities in ICU nutrition for resource-limited settings.
Research priorities identified from statements reaching no consensus after repeated rating, and from themes in panellists' free-text comments, analysed thematically.
Time frame: Through study completion, an average of 18 months
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual participant data will not be shared. Participants consented to their responses being reported only in aggregate, and the small expert panel carries a risk of re-identification. Aggregate results for each statement will be published in the final manuscript.
Start is estimated for Jan 2027; primary completion for Dec 2027, 11 months later.
Of 441 non-industry observational studies under Critical Illness, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 11 months is below that.
Counting every sponsor, half of 444 studies reached it within 23 months; a quarter within 12 and three quarters within 46.
Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.